Regencell Bioscience (NASDAQ: RGC)
$5.21
(2.5%)
$0.13
Price as of May 15, 2024, 2:39 p.m. ET
Regencell Bioscience Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Regencell Bioscience Company Info
Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. It seeks for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder and autism spectrum disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.
News & Analysis
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.